AIM ImmunoTech Inc (AIM)

0.19 0.00 (0.00%) USD  |  NYAM  |  Dec 20, 16:00
0.195 0.00 (0.00%) Pre-Market: 20:00
More

AIM ImmunoTech Debt to Equity Ratio: 0.9382 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Perspective Therapeutics Inc --
Protalix BioTherapeutics Inc 0.00
Electromed Inc 0.00
Xtant Medical Holdings Inc 0.7605
Armata Pharmaceuticals Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 13.59M
Total Liabilities (Quarterly) 10.68M
Shareholders Equity (Quarterly) 2.912M
Current Ratio 0.7495
Net Debt Paydown Yield -3.45%